Global Diagnostic Nuclear Drug Market Growth (Status and Outlook) 2020-2025
According to this study, over the next five years the Diagnostic Nuclear Drug market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Diagnostic Nuclear Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Diagnostic Nuclear Drug market by type, application, key companies and key regions.
This study considers the Diagnostic Nuclear Drug value generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Tc-99m
F-18
Other
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Oncology
Cardiology
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bracco Imaging
Eli Lilly
Bayer
Nordion
Triad Isotopes
Curium Pharmaceuticals
China Isotope & Radiation
Lantheus
Jubilant Pharma
GE Healthcare
Novartis
Navidea
Dongcheng
SIEMENS
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Diagnostic Nuclear Drug market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Diagnostic Nuclear Drug market by identifying its various subsegments.
Focuses on the key global Diagnostic Nuclear Drug players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Diagnostic Nuclear Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Diagnostic Nuclear Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Diagnostic Nuclear Drug Market Size 2015-2025
2.1.2 Diagnostic Nuclear Drug Market Size CAGR by Region
2.2 Diagnostic Nuclear Drug Segment by Type
2.2.1 Tc-99m
2.2.2 Tc-99m
2.2.3 Other
2.3 Diagnostic Nuclear Drug Market Size by Type
2.3.1 Global Diagnostic Nuclear Drug Market Size Market Share by Type (2015-2020)
2.3.2 Global Diagnostic Nuclear Drug Market Size Growth Rate by Type (2015-2020)
2.4 Diagnostic Nuclear Drug Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Diagnostic Nuclear Drug Market Size by Application
2.5.1 Global Diagnostic Nuclear Drug Market Size Market Share by Application (2015-2020)
2.5.2 Global Diagnostic Nuclear Drug Market Size Growth Rate by Application (2015-2020)
3 Global Diagnostic Nuclear Drug by Players
3.1 Global Diagnostic Nuclear Drug Market Size Market Share by Players
3.1.1 Global Diagnostic Nuclear Drug Market Size by Players (2018-2020)
3.1.2 Global Diagnostic Nuclear Drug Market Size Market Share by Players (2018-2020)
3.2 Global Diagnostic Nuclear Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Diagnostic Nuclear Drug by Regions
4.1 Diagnostic Nuclear Drug Market Size by Regions
4.2 Americas Diagnostic Nuclear Drug Market Size Growth
4.3 APAC Diagnostic Nuclear Drug Market Size Growth
4.4 Europe Diagnostic Nuclear Drug Market Size Growth
4.5 Middle East & Africa Diagnostic Nuclear Drug Market Size Growth
5 Americas
5.1 Americas Diagnostic Nuclear Drug Market Size by Countries
5.2 Americas Diagnostic Nuclear Drug Market Size by Type
5.3 Americas Diagnostic Nuclear Drug Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Diagnostic Nuclear Drug Market Size by Regions
6.2 APAC Diagnostic Nuclear Drug Market Size by Type
6.3 APAC Diagnostic Nuclear Drug Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Diagnostic Nuclear Drug by Countries
7.2 Europe Diagnostic Nuclear Drug Market Size by Type
7.3 Europe Diagnostic Nuclear Drug Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Diagnostic Nuclear Drug by Countries
8.2 Middle East & Africa Diagnostic Nuclear Drug Market Size by Type
8.3 Middle East & Africa Diagnostic Nuclear Drug Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Diagnostic Nuclear Drug Market Forecast
10.1 Global Diagnostic Nuclear Drug Market Size Forecast (2021-2025)
10.2 Global Diagnostic Nuclear Drug Forecast by Regions
10.2.1 Global Diagnostic Nuclear Drug Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Diagnostic Nuclear Drug Forecast by Type
10.8 Global Diagnostic Nuclear Drug Forecast by Application
11 Key Players Analysis
11.1 Bracco Imaging
11.1.1 Company Details
11.1.2 Diagnostic Nuclear Drug Product Offered
11.1.3 Bracco Imaging Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Bracco Imaging News
11.2 Eli Lilly
11.2.1 Company Details
11.2.2 Diagnostic Nuclear Drug Product Offered
11.2.3 Eli Lilly Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Eli Lilly News
11.3 Bayer
11.3.1 Company Details
11.3.2 Diagnostic Nuclear Drug Product Offered
11.3.3 Bayer Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Bayer News
11.4 Nordion
11.4.1 Company Details
11.4.2 Diagnostic Nuclear Drug Product Offered
11.4.3 Nordion Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Nordion News
11.5 Triad Isotopes
11.5.1 Company Details
11.5.2 Diagnostic Nuclear Drug Product Offered
11.5.3 Triad Isotopes Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Triad Isotopes News
11.6 Curium Pharmaceuticals
11.6.1 Company Details
11.6.2 Diagnostic Nuclear Drug Product Offered
11.6.3 Curium Pharmaceuticals Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Curium Pharmaceuticals News
11.7 China Isotope & Radiation
11.7.1 Company Details
11.7.2 Diagnostic Nuclear Drug Product Offered
11.7.3 China Isotope & Radiation Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 China Isotope & Radiation News
11.8 Lantheus
11.8.1 Company Details
11.8.2 Diagnostic Nuclear Drug Product Offered
11.8.3 Lantheus Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Lantheus News
11.9 Jubilant Pharma
11.9.1 Company Details
11.9.2 Diagnostic Nuclear Drug Product Offered
11.9.3 Jubilant Pharma Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Jubilant Pharma News
11.10 GE Healthcare
11.10.1 Company Details
11.10.2 Diagnostic Nuclear Drug Product Offered
11.10.3 GE Healthcare Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 GE Healthcare News
11.11 Novartis
11.12 Navidea
11.13 Dongcheng
11.14 SIEMENS
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Diagnostic Nuclear Drug Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Tc-99m
Table 5. Major Players of F-18
Table 6. Major Players of Other
Table 7. Diagnostic Nuclear Drug Market Size by Type (2014-2019) ($ Millions)
Table 8. Global Diagnostic Nuclear Drug Market Size Market Share by Type (2015-2020)
Table 9. Global Diagnostic Nuclear Drug Market Size by Application (2015-2020) ($ Millions)
Table 10. Global Diagnostic Nuclear Drug Market Size Market Share by Application (2015-2020)
Table 11. Global Diagnostic Nuclear Drug Revenue by Players (2018-2020) ($ Millions)
Table 12. Global Diagnostic Nuclear Drug Revenue Market Share by Players (2018-2020)
Table 13. Global Diagnostic Nuclear Drug Key Players Head office and Products Offered
Table 14. Diagnostic Nuclear Drug Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Diagnostic Nuclear Drug Market Size by Regions 2015-2020 ($ Millions)
Table 18. Global Diagnostic Nuclear Drug Market Size Market Share by Regions 2015-2020
Table 19. Americas Diagnostic Nuclear Drug Market Size by Countries (2015-2020) ($ Millions)
Table 20. Americas Diagnostic Nuclear Drug Market Size Market Share by Countries (2015-2020)
Table 21. Americas Diagnostic Nuclear Drug Market Size by Type (2015-2020) ($ Millions)
Table 22. Americas Diagnostic Nuclear Drug Market Size Market Share by Type (2015-2020)
Table 23. Americas Diagnostic Nuclear Drug Market Size by Application (2015-2020) ($ Millions)
Table 24. Americas Diagnostic Nuclear Drug Market Size Market Share by Application (2015-2020)
Table 25. APAC Diagnostic Nuclear Drug Market Size by Regions (2015-2020) ($ Millions)
Table 26. APAC Diagnostic Nuclear Drug Market Size Market Share by Regions (2015-2020)
Table 27. APAC Diagnostic Nuclear Drug Market Size by Type (2015-2020) ($ Millions)
Table 28. APAC Diagnostic Nuclear Drug Market Size Market Share by Type (2015-2020)
Table 29. APAC Diagnostic Nuclear Drug Market Size by Application (2015-2020) ($ Millions)
Table 30. APAC Diagnostic Nuclear Drug Market Size Market Share by Application (2015-2020)
Table 31. Europe Diagnostic Nuclear Drug Market Size by Countries (2015-2020) ($ Millions)
Table 32. Europe Diagnostic Nuclear Drug Market Size Market Share by Countries (2015-2020)
Table 33. Europe Diagnostic Nuclear Drug Market Size by Type (2015-2020) ($ Millions)
Table 34. Europe Diagnostic Nuclear Drug Market Size Market Share by Type (2015-2020)
Table 35. Europe Diagnostic Nuclear Drug Market Size by Application (2015-2020) ($ Millions)
Table 36. Europe Diagnostic Nuclear Drug Market Size Market Share by Application (2015-2020)
Table 37. Middle East & Africa Diagnostic Nuclear Drug Market Size by Countries (2015-2020) ($ Millions)
Table 38. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Countries (2015-2020)
Table 39. Middle East & Africa Diagnostic Nuclear Drug Market Size by Type (2015-2020) ($ Millions)
Table 40. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Type (2015-2020)
Table 41. Middle East & Africa Diagnostic Nuclear Drug Market Size by Application (2015-2020) ($ Millions)
Table 42. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Application (2015-2020)
Table 43. Key and Potential Regions of Diagnostic Nuclear Drug
Table 44. Key Application and Potential Industries of Diagnostic Nuclear Drug
Table 45. Key Challenges of Diagnostic Nuclear Drug
Table 46. Key Trends of Diagnostic Nuclear Drug
Table 47. Global Diagnostic Nuclear Drug Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 48. Global Diagnostic Nuclear Drug Market Size Market Share Forecast by Regions
Table 49. Global Diagnostic Nuclear Drug Market Size Forecast by Type (2021-2025) ($ Millions)
Table 50. Global Diagnostic Nuclear Drug Market Size Market Share Forecast by Type (2021-2025)
Table 51. Global Diagnostic Nuclear Drug Market Size Forecast by Application (2021-2025) ($ Millions)
Table 52. Global Diagnostic Nuclear Drug Market Size Market Share Forecast by Application (2021-2025)
Table 53. Bracco Imaging Details, Company Total Revenue (in $ million), Head Office, Diagnostic Nuclear Drug Major Market Areas and Its Competitors
Table 54. Bracco Imaging Diagnostic Nuclear Drug Product Offered
Table 55. Bracco Imaging Diagnostic Nuclear Drug Revenue and Gross Margin (2018-2020E)
Table 56. Bracco Imaging Main Business
Table 57. Bracco Imaging Latest Developments
Table 58. Eli Lilly Details, Company Total Revenue (in $ million), Head Office, Diagnostic Nuclear Drug Major Market Areas and Its Competitors
Table 59. Eli Lilly Diagnostic Nuclear Drug Product Offered
Table 60. Eli Lilly Main Business
Table 61. Eli Lilly Diagnostic Nuclear Drug Revenue and Gross Margin (2018-2020E)
Table 62. Eli Lilly Latest Developments
Table 63. Bayer Details, Company Total Revenue (in $ million), Head Office, Diagnostic Nuclear Drug Major Market Areas and Its Competitors
Table 64. Bayer Diagnostic Nuclear Drug Product Offered
Table 65. Bayer Main Business
Table 66. Bayer Diagnostic Nuclear Drug Revenue and Gross Margin (2018-2020E)
Table 67. Bayer Latest Developments
Table 68. Nordion Details, Company Total Revenue (in $ million), Head Office, Diagnostic Nuclear Drug Major Market Areas and Its Competitors
Table 69. Nordion Diagnostic Nuclear Drug Product Offered
Table 70. Nordion Main Business
Table 71. Nordion Diagnostic Nuclear Drug Revenue and Gross Margin (2018-2020E)
Table 72. Nordion Latest Developments
Table 73. Triad Isotopes Details, Company Total Revenue (in $ million), Head Office, Diagnostic Nuclear Drug Major Market Areas and Its Competitors
Table 74. Triad Isotopes Diagnostic Nuclear Drug Product Offered
Table 75. Triad Isotopes Main Business
Table 76. Triad Isotopes Diagnostic Nuclear Drug Revenue and Gross Margin (2018-2020E)
Table 77. Triad Isotopes Latest Developments
Table 78. Curium Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Diagnostic Nuclear Drug Major Market Areas and Its Competitors
Table 79. Curium Pharmaceuticals Diagnostic Nuclear Drug Product Offered
Table 80. Curium Pharmaceuticals Main Business
Table 81. Curium Pharmaceuticals Diagnostic Nuclear Drug Revenue and Gross Margin (2018-2020E)
Table 82. Curium Pharmaceuticals Latest Developments
Table 83. China Isotope & Radiation Details, Company Total Revenue (in $ million), Head Office, Diagnostic Nuclear Drug Major Market Areas and Its Competitors
Table 84. China Isotope & Radiation Diagnostic Nuclear Drug Product Offered
Table 85. China Isotope & Radiation Main Business
Table 86. China Isotope & Radiation Diagnostic Nuclear Drug Revenue and Gross Margin (2018-2020E)
Table 87. China Isotope & Radiation Latest Developments
Table 88. Lantheus Details, Company Total Revenue (in $ million), Head Office, Diagnostic Nuclear Drug Major Market Areas and Its Competitors
Table 89. Lantheus Diagnostic Nuclear Drug Product Offered
Table 90. Lantheus Main Business
Table 91. Lantheus Diagnostic Nuclear Drug Revenue and Gross Margin (2018-2020E)
Table 92. Lantheus Latest Developments
Table 93. Jubilant Pharma Details, Company Total Revenue (in $ million), Head Office, Diagnostic Nuclear Drug Major Market Areas and Its Competitors
Table 94. Jubilant Pharma Diagnostic Nuclear Drug Product Offered
Table 95. Jubilant Pharma Main Business
Table 96. Jubilant Pharma Diagnostic Nuclear Drug Revenue and Gross Margin (2018-2020E)
Table 97. Jubilant Pharma Latest Developments
Table 98. GE Healthcare Details, Company Total Revenue (in $ million), Head Office, Diagnostic Nuclear Drug Major Market Areas and Its Competitors
Table 99. GE Healthcare Diagnostic Nuclear Drug Product Offered
Table 100. GE Healthcare Main Business
Table 101. GE Healthcare Diagnostic Nuclear Drug Revenue and Gross Margin (2018-2020E)
Table 102. GE Healthcare Latest Developments
Table 103. Novartis Details, Company Total Revenue (in $ million), Head Office, Diagnostic Nuclear Drug Major Market Areas and Its Competitors
Table 104. Navidea Details, Company Total Revenue (in $ million), Head Office, Diagnostic Nuclear Drug Major Market Areas and Its Competitors
Table 105. Dongcheng Details, Company Total Revenue (in $ million), Head Office, Diagnostic Nuclear Drug Major Market Areas and Its Competitors
Table 106. SIEMENS Details, Company Total Revenue (in $ million), Head Office, Diagnostic Nuclear Drug Major Market Areas and Its Competitors
List of Figures
Figure 1. Diagnostic Nuclear Drug Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Diagnostic Nuclear Drug Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Diagnostic Nuclear Drug Market Size Market Share by Type (2015-2020)
Figure 5. Global Tc-99m Market Size Growth Rate
Figure 6. Global F-18 Market Size Growth Rate
Figure 7. Global Other Market Size Growth Rate
Figure 8. Diagnostic Nuclear Drug in Oncology
Figure 9. Global Diagnostic Nuclear Drug Market: Oncology (2015-2020) ($ Millions)
Figure 10. Diagnostic Nuclear Drug in Cardiology
Figure 11. Global Diagnostic Nuclear Drug Market: Cardiology (2015-2020) ($ Millions)
Figure 12. Diagnostic Nuclear Drug in Other
Figure 13. Global Diagnostic Nuclear Drug Market: Other (2015-2020) ($ Millions)
Figure 14. Global Other YoY Growth ($ Millions)
Figure 15. Global Diagnostic Nuclear Drug Market Size Market Share by Application in 2019
Figure 16. Global Diagnostic Nuclear Drug Market Size Market Share by Regions 2015-2020
Figure 17. Americas Diagnostic Nuclear Drug Market Size 2015-2020 ($ Millions)
Figure 18. APAC Diagnostic Nuclear Drug Market Size 2015-2020 ($ Millions)
Figure 19. Europe Diagnostic Nuclear Drug Market Size 2015-2020 ($ Millions)
Figure 20. Middle East & Africa Diagnostic Nuclear Drug Market Size 2015-2020 ($ Millions)
Figure 21. Americas Diagnostic Nuclear Drug Market Size Market Share by Countries in 2019
Figure 22. Americas Diagnostic Nuclear Drug Market Size Market Share by Type in 2019
Figure 23. Americas Diagnostic Nuclear Drug Market Size Market Share by Application in 2019
Figure 24. United States Diagnostic Nuclear Drug Market Size Growth 2015-2020 ($ Millions)
Figure 25. Canada Diagnostic Nuclear Drug Market Size Growth 2015-2020 ($ Millions)
Figure 26. Mexico Diagnostic Nuclear Drug Market Size Growth 2015-2020 ($ Millions)
Figure 27. APAC Diagnostic Nuclear Drug Market Size Market Share by Regions in 2019
Figure 28. APAC Diagnostic Nuclear Drug Market Size Market Share by Type in 2019
Figure 29. APAC Diagnostic Nuclear Drug Market Size Market Share by Application in 2019
Figure 30. China Diagnostic Nuclear Drug Market Size Growth 2015-2020 ($ Millions)
Figure 31. Japan Diagnostic Nuclear Drug Market Size Growth 2015-2020 ($ Millions)
Figure 32. Korea Diagnostic Nuclear Drug Market Size Growth 2015-2020 ($ Millions)
Figure 33. Southeast Asia Diagnostic Nuclear Drug Market Size Growth 2015-2020 ($ Millions)
Figure 34. India Diagnostic Nuclear Drug Market Size Growth 2015-2020 ($ Millions)
Figure 35. Australia Diagnostic Nuclear Drug Market Size Growth 2015-2020 ($ Millions)
Figure 36. Europe Diagnostic Nuclear Drug Market Size Market Share by Countries in 2019
Figure 37. Europe Diagnostic Nuclear Drug Market Size Market Share by Type in 2019
Figure 38. Europe Diagnostic Nuclear Drug Market Size Market Share by Application in 2019
Figure 39. Germany Diagnostic Nuclear Drug Market Size Growth 2015-2020 ($ Millions)
Figure 40. France Diagnostic Nuclear Drug Market Size Growth 2015-2020 ($ Millions)
Figure 41. UK Diagnostic Nuclear Drug Market Size Growth 2015-2020 ($ Millions)
Figure 42. Italy Diagnostic Nuclear Drug Market Size Growth 2015-2020 ($ Millions)
Figure 43. Russia Diagnostic Nuclear Drug Market Size Growth 2015-2020 ($ Millions)
Figure 44. Spain Diagnostic Nuclear Drug Market Size Growth 2015-2020 ($ Millions)
Figure 45. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Countries in 2019
Figure 46. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Type in 2019
Figure 47. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Application in 2019
Figure 48. Egypt Diagnostic Nuclear Drug Market Size Growth 2015-2020 ($ Millions)
Figure 49. South Africa Diagnostic Nuclear Drug Market Size Growth 2015-2020 ($ Millions)
Figure 50. Israel Diagnostic Nuclear Drug Market Size Growth 2015-2020 ($ Millions)
Figure 51. Turkey Diagnostic Nuclear Drug Market Size Growth 2015-2020 ($ Millions)
Figure 52. GCC Countries Diagnostic Nuclear Drug Market Size Growth 2015-2020 ($ Millions)
Figure 53. Global Diagnostic Nuclear Drug arket Size Forecast (2021-2025) ($ Millions)
Figure 54. Americas Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 55. APAC Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 56. Europe Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 57. Middle East & Africa Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 58. United States Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 59. Canada Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 60. Mexico Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 61. Brazil Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 62. China Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 63. Japan Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 64. Korea Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 65. Southeast Asia Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 66. India Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 67. Australia Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 68. Germany Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 69. France Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 70. UK Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 71. Italy Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 72. Russia Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 73. Spain Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 74. Egypt Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 75. South Africa Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 76. Israel Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 77. Turkey Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Figure 78. GCC Countries Diagnostic Nuclear Drug Market Size 2021-2025 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets